{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:01:30Z","timestamp":1790240490529,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.thromres.2026.109809","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:15:23Z","timestamp":1787926523000},"page":"109809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Polyendocrine metabolic ovarian syndrome and venous thromboembolism: Hemostatic considerations in diagnosis and management"],"prefix":"10.1016","volume":"265","author":[{"given":"Vilmarie","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Sokkary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel P.","family":"Rosovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda V.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Tasset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany Samuelson","family":"Bannow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clay T.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhvi","family":"Rajpurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.thromres.2026.109809_bb0005","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.thromres.2026.109809_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(26)00717-8","article-title":"Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process","author":"Teede","year":"2026","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.thromres.2026.109809_bb0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2026.1370","article-title":"Ovarian cysts in polycystic ovary syndrome","author":"Piltonen","year":"2026","journal-title":"JAMA Intern. Med."},{"issue":"Supplement 1","key":"10.1016\/j.thromres.2026.109809_bb0020","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1182\/blood-2023-190997","article-title":"Increased risk of thrombosis in patients with polycystic ovarian syndrome","volume":"142","author":"Miller","year":"2023","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2026.109809_bb0025","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1503\/cmaj.120677","article-title":"Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis","volume":"185","author":"Bird","year":"2013","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.thromres.2026.109809_bb0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2019.11.019","article-title":"Association between polycystic ovary syndrome and venous thromboembolism: a systematic review and meta-analysis","volume":"185","author":"Gariani","year":"2020","journal-title":"Thromb. Res."},{"issue":"12","key":"10.1016\/j.thromres.2026.109809_bb0035","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1016\/j.jtha.2024.08.012","article-title":"The changing face of cerebral venous sinus thrombosis-emerging new causes and treatments","volume":"22","author":"Dix","year":"2024","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2026.109809_bb0040","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1210\/jc.2010-2279","article-title":"Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome","volume":"96","author":"Manner\u00e5s-Holm","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.thromres.2026.109809_bb0045","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"17","key":"10.1016\/j.thromres.2026.109809_bb0050","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.thromres.2026.109809_bb0055","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/MOH.0b013e3283634443","article-title":"Mechanisms of thrombosis in obesity","volume":"20","author":"Blokhin","year":"2013","journal-title":"Curr. Opin. Hematol."},{"issue":"3","key":"10.1016\/j.thromres.2026.109809_bb0060","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0037-1613379","article-title":"Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use","volume":"89","author":"Abdollahi","year":"2003","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2026.109809_bb0065","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12916-020-01516-x","article-title":"Adolescent polycystic ovary syndrome according to the international evidence-based guideline","volume":"18","author":"Pe\u00f1a","year":"2020","journal-title":"BMC Med."},{"issue":"5","key":"10.1016\/j.thromres.2026.109809_bb0070","doi-asserted-by":"crossref","first-page":"377.e1","DOI":"10.1016\/j.ajog.2012.08.007","article-title":"Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008","volume":"207","author":"Okoroh","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.thromres.2026.109809_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073789","article-title":"Chronic low grade inflammation in pathogenesis of PCOS","volume":"22","author":"Rudnicka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.thromres.2026.109809_bb0080","article-title":"A systematic review of inflammatory markers in polycystic ovary syndrome (PCOS) and meta-analysis of interleukin-6 (IL-6) in case-control studies","volume":"17","author":"Bansal","year":"2025","journal-title":"Cureus"},{"issue":"11","key":"10.1016\/j.thromres.2026.109809_bb0085","article-title":"Beyond hormones: a systematic review of the risk of cardiovascular diseases in polycystic ovary syndrome","volume":"16","author":"Dutta","year":"2024","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.thromres.2026.109809_bb0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood-2008-01-077909","article-title":"Advances in understanding pathogenic mechanisms of thrombophilic disorders","volume":"112","author":"Dahlb\u00e4ck","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2026.109809_bb0095","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood.2019000917","article-title":"Managing thromboembolic risk in patients with hereditary and acquired thrombophilias","volume":"135","author":"Moran","year":"2020","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2026.109809_bb0100","article-title":"A call to action: MTHFR polymorphisms should not be a part of inherited thrombophilia testing","volume":"6","author":"The","year":"2022","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2026.109809_bb0105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/AOG.0000000000002705","article-title":"ACOG practice bulletin no. 197 summary: inherited thrombophilias in pregnancy","volume":"132","year":"2018","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.thromres.2026.109809_bb0110","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/humrep\/17.2.314","article-title":"Polycystic ovarian syndrome and thrombophilia","volume":"17","author":"Tsanadis","year":"2002","journal-title":"Hum. Reprod."},{"issue":"22","key":"10.1016\/j.thromres.2026.109809_bb0115","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.thromres.2026.109809_bb0120","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archinternmed.2008.589","article-title":"The value of family history as a risk indicator for venous thrombosis","volume":"169","author":"Bezemer","year":"2009","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.thromres.2026.109809_bb0125","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis","volume":"26","author":"Wekker","year":"2020","journal-title":"Hum. Reprod. Update"},{"issue":"4","key":"10.1016\/j.thromres.2026.109809_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"Nguyen","year":"2024","journal-title":"MMWR Recomm. Rep."},{"issue":"1","key":"10.1016\/j.thromres.2026.109809_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fertnstert.2016.09.027","article-title":"Combined hormonal contraception and the risk of venous thromboembolism: a guideline","volume":"107","year":"2017","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.thromres.2026.109809_bb0140","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ\u202f[Br. Med. J.]"},{"issue":"3","key":"10.1016\/j.thromres.2026.109809_bb0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijgo.12455","article-title":"A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception","volume":"141","author":"Dragoman","year":"2018","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"22","key":"10.1016\/j.thromres.2026.109809_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262211010","article-title":"Combined oral contraceptives and the risk of thrombosis","volume":"26","author":"Khizroeva","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"07","key":"10.1016\/j.thromres.2026.109809_bb0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0037-1613960","article-title":"A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways","volume":"84","author":"Tans","year":"2000","journal-title":"Thromb. Haemost."},{"issue":"18","key":"10.1016\/j.thromres.2026.109809_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814179","article-title":"The fibrinolytic system and its measurement: history, current uses and future directions for diagnosis and treatment","volume":"24","author":"Hvas","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.thromres.2026.109809_bb0165","first-page":"9","article-title":"Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives","volume":"84","author":"Meijers","year":"2000","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109809_bb0170","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0049-3848(13)70009-4","article-title":"Mechanisms of hormonal therapy related thrombosis","volume":"131","author":"Sandset","year":"2013","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2026.109809_bb0175","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.thromres.2021.03.012","article-title":"Oral contraceptives and hormone replacement therapy: how strong a risk factor for venous thromboembolism?","volume":"202","author":"Skeith","year":"2021","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2026.109809_bb0180","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10","volume":"344","author":"Lidegaard","year":"2012","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"10.1016\/j.thromres.2026.109809_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2025.110861","article-title":"Estetrol\/drospirenone safety in a population with cardiovascular risk factors","author":"Creinin","year":"2025","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.thromres.2026.109809_bb0190","first-page":"1976","article-title":"Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS)","volume":"83","author":"Cronin","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.thromres.2026.109809_bb0195","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehag252","article-title":"Lipoprotein(a) and incident venous thromboembolism in pre- and postmenopausal women, and in men","author":"Ezzat","year":"2026","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.thromres.2026.109809_bb0200","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1186\/s12905-023-02703-7","article-title":"Association between oral contraceptives with lipid profile: results from Hoveyzeh cohort study (HCS)","volume":"23","author":"Hashemi","year":"2023","journal-title":"BMC Womens Health"},{"issue":"8","key":"10.1016\/j.thromres.2026.109809_bb0205","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41371-022-00771-0","article-title":"Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases","volume":"37","author":"Visniauskas","year":"2023","journal-title":"J. Hum. Hypertens."},{"issue":"1","key":"10.1016\/j.thromres.2026.109809_bb0210","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12944-017-0612-5","article-title":"The effects of progesterones on blood lipids in hormone replacement therapy","volume":"16","author":"Jiang","year":"2017","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.thromres.2026.109809_bb0215","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1182\/hematology.2024000591","article-title":"Estrogen, progestin, and beyond: thrombotic risk and contraceptive choices","volume":"2024","author":"Skeith","year":"2024","journal-title":"Hematology"},{"key":"10.1016\/j.thromres.2026.109809_bb0220","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e4944","article-title":"Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis","volume":"345","author":"Mantha","year":"2012","journal-title":"BMJ"},{"issue":"9190","key":"10.1016\/j.thromres.2026.109809_bb0225","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)04394-9","article-title":"Risk of idiopathic venous thromboembolism in users of progestagens alone","volume":"354","author":"Vasilakis","year":"1999","journal-title":"Lancet"},{"issue":"9190","key":"10.1016\/j.thromres.2026.109809_bb0230","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)03132-3","article-title":"Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications","volume":"354","author":"Poulter","year":"1999","journal-title":"Lancet"},{"issue":"11, Supplement","key":"10.1016\/j.thromres.2026.109809_bb0235","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.jmig.2021.09.454","article-title":"Non-contraceptive progestins and risk of venous thromboembolism: a nested case-control study of the Marketscan databases","volume":"28","author":"Cockrum","year":"2021","journal-title":"J. Minim. Invasive Gynecol."},{"issue":"11","key":"10.1016\/j.thromres.2026.109809_bb0240","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2026.109809_bb0245","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1538-7836.2012.04662.x","article-title":"Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH","volume":"10","author":"Baglin","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2026.109809_bb0250","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/humupd\/dmr042","article-title":"Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"18","author":"Escobar-Morreale","year":"2012","journal-title":"Hum. Reprod. Update"},{"issue":"5","key":"10.1016\/j.thromres.2026.109809_bb0255","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jmig.2012.05.009","article-title":"Diagnosis and management of endometrial hyperplasia","volume":"19","author":"Armstrong","year":"2012","journal-title":"J. Minim. Invasive Gynecol."},{"issue":"2","key":"10.1016\/j.thromres.2026.109809_bb0260","first-page":"281","article-title":"Polycystic ovary syndrome, metabolic syndrome, cardiovascular risk and the role of insulin sensitizing agents","volume":"50","author":"Silva Rdo","year":"2006","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"issue":"5","key":"10.1016\/j.thromres.2026.109809_bb0265","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/aje\/kwab291","article-title":"Association of metformin use with risk of venous thromboembolism in adults with type 2 diabetes: a general-population-based cohort study","volume":"191","author":"Sha","year":"2022","journal-title":"Am. J. Epidemiol."},{"issue":"10","key":"10.1016\/j.thromres.2026.109809_bb0270","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.metabol.2015.06.011","article-title":"Increased thrombin generation in women with polycystic ovary syndrome: a pilot study on the effect of metformin and oral contraceptives","volume":"64","author":"Glintborg","year":"2015","journal-title":"Metabolism"},{"issue":"11","key":"10.1016\/j.thromres.2026.109809_bb0275","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1160\/TH17-04-0248","article-title":"Differential effects on haemostatic markers by metformin and the contraceptive pill: a randomized comparative trial in PCOS","volume":"117","author":"Burchall","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2026.109809_bb0280","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00404-017-4471-0","article-title":"Metformin reduces total microparticles and microparticles-expressing tissue factor in women with polycystic ovary syndrome","volume":"296","author":"Carvalho","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"issue":"5","key":"10.1016\/j.thromres.2026.109809_bb0285","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.thromres.2011.08.020","article-title":"Circulating microparticles and risk of venous thromboembolism","volume":"129","author":"Bucciarelli","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2026.109809_bb0290","article-title":"Recent advances in individualized clinical strategies for polycystic ovary syndrome: evidence from clinical trials and emerging pharmacotherapies","author":"Moka","year":"2024","journal-title":"Clin. Ther."},{"issue":"6","key":"10.1016\/j.thromres.2026.109809_bb0295","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.jaad.2023.02.028","article-title":"Spironolactone use for acne is not associated with an increased risk of venous thromboembolism: a matched, retrospective cohort study","volume":"88","author":"Shields","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.thromres.2026.109809_bb0300","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1477-7827-9-86","article-title":"Letrozole or clomiphene citrate as first line for anovulatory infertility: a debate","volume":"9","author":"Kamath","year":"2011","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.thromres.2026.109809_bb0305","article-title":"Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis","volume":"356","author":"Wang","year":"2017","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.thromres.2026.109809_bb0310","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1093\/humrep\/deq247","article-title":"Mild ovarian stimulation for IVF: 10 years later","volume":"25","author":"Fauser","year":"2010","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.thromres.2026.109809_bb0315","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.fertnstert.2019.09.020","article-title":"Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion","volume":"113","year":"2020","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.thromres.2026.109809_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14041053","article-title":"Risk of thrombosis in women undergoing in vitro fertilization: a narrative review","volume":"14","author":"Grandone","year":"2025","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.thromres.2026.109809_bb0325","first-page":"1459","article-title":"Polycystic ovary syndrome develops the complications of assisted reproductive technologies","volume":"77","author":"Alhilali","year":"2022","journal-title":"Arch. Razi Inst."},{"issue":"9","key":"10.1016\/j.thromres.2026.109809_bb0330","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/aogs.13147","article-title":"Thromboembolism and in vitro fertilization - a systematic review","volume":"96","author":"Sennstr\u00f6m","year":"2017","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"8","key":"10.1016\/j.thromres.2026.109809_bb0335","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/jth.14840","article-title":"Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilization with fresh respectively frozen-thawed embryo transfer: nationwide cohort study","volume":"18","author":"Olausson","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2026.109809_bb0340","doi-asserted-by":"crossref","DOI":"10.1080\/14647273.2024.2352387","article-title":"Venous thromboembolism associated with medically assisted reproduction (MAR): British Fertility Society policy and practice guidance for assessment and prevention","volume":"27","author":"Balachandren","year":"2024","journal-title":"Hum. Fertil."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826002288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826002288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:17:43Z","timestamp":1790237863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826002288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":68,"alternative-id":["S0049384826002288"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109809","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyendocrine metabolic ovarian syndrome and venous thromboembolism: Hemostatic considerations in diagnosis and management","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109809"}}